Pharmaceutical Product Supply – Meloxicam Tablets, 15mg

The contract entails the supply of FDA-approved Meloxicam Tablets in 15mg strength, packaged in unit-dose format with 50 tablets per unit, fully compliant with DLA technical standards and all applicable military packaging and marking requirements including MIL-STD-2073-1E for packaging and MIL-STD-129 for labeling. The product must meet stringent quality and documentation criteria to ensure interoperability and traceability within Department of Defense medical supply chains. The place of performance is specified as Fort Stewart, Georgia, with a zip code of 31314-5185, indicating the designated delivery location for the finalized product. This subcontract, posted on May 10, 2026, has a response deadline of May 18, 2026, and is classified under NAICS code 325412, which corresponds to pharmaceutical and medicinal product manufacturing. The contracting organization is the Medical Supply Chain Pharm FSA under the Department of Defense, and the solicitation is accessible via the DIBBS portal. There is no set-aside designation specified, meaning the contract is open to all eligible bidders without preference for small businesses or other categories. All submissions must adhere to the technical and regulatory frameworks outlined to ensure the product is suitable for military medical use.